Company: MYSEW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076607
Chunk: 164

Company: Myseum, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 2
Chunk 164
---
 an increase
in contract liabilities of $17, and a decrease in operating lease liabilities of $3,562.

Net cash flow used in operating activities for
the six months ended June 30, 2024 primarily reflected a net loss of $2,765,915 adjusted for the add-back (reduction) of non-cash items
consisting of depreciation and amortization of $11,565, amortization of right of use assets of $35,131, accretion of stock-based stock
option and common stock expense of $116,698, a non-cash gain from deconsolidation of variable interest entities of $(107), and foreign
currency exchange loss of $12,965, offset by changes in operating assets and liabilities primarily consisting of an increase in accounts
receivable of $9, a decrease in prepaid expenses of $40,207, an increase in accounts payable and accrued expenses of $38,693, an increase
in contract liabilities of $25, and a decrease in operating lease liabilities of $39,637. 

Cash Flows from Investing Activities

Net cash provided by (used in) investing activities
amounted to $(2,533,305) and $527,769 for the six months ended June 30, 2025 and 2024, respectively.

During the six months ended June 30, 2025, we
received gross proceeds from the sale of short-term investments of $2,963,546 and purchased short-term investments of $5,317,735. Additionally,
we purchased property and equipment of $4,475 and capitalized internal-use software of $174,641.

During the six months ended June 30, 2024, we
received gross proceeds from the sale of short-term investments of $6,121,770 purchased short-term investments of $5,594,001.

Cash Flows from Financing Activities

Net cash provided by financing activities totaled
4,355,472 and $1,656,771 for the six months ended June 30, 2025 and 2024, respectively.

During the six months ended June 30, 2025, we
received $4,532,000 from the sale of common stock, net, and paid deferred offering costs of $176,528.

During the six months ended June 30, 2024, we
received $559,251 from the sale of common stock, net, received $235,998 from the sale of subsidiary common stock, net